SkyDrive, Air India And Suzuki To Assess eVTOL Medical Logistics Routes In India
SkyDrive, Air India and Suzuki Motor Corporation are set to evaluate potential routes for eVTOL-based medical logistics in India, focusing initially on urgent pharmaceutical, organ and medical transport.
The companies signed a memorandum of understanding in July to study the feasibility of using electric vertical takeoff and landing aircraft for medical logistics. The latest phase will identify and assess specific routes where eVTOL operations could potentially address delays caused by road congestion.



One proposed use case involves the transport of radioactive isotopes used in cancer diagnosis and treatment. Because these pharmaceuticals can have short half-lives, the companies will examine a potential route between a manufacturing facility in Mumbai and major hospitals in the surrounding area. The study will consider whether an air-based service could reduce delays and help prevent the degradation of time-sensitive medicines.
A second focus is emergency medical and organ transport in the Delhi National Capital Region. SkyDrive said the study will assess whether eVTOLs could reduce inter-hospital journeys that can currently take between 30 and 90 minutes by road to approximately 10 to 15 minutes by air.
The partners are also expanding the study beyond medical applications. They plan to examine whether eVTOLs could transport aircraft components between parts collection hubs or maintenance bases near Delhi Indira Gandhi International Airport and airport terminals or maintenance facilities.
The latter use case is aimed at addressing aircraft-on-ground situations, where delays in obtaining replacement parts can extend maintenance downtime. The study will consider whether bypassing road congestion could improve the speed of parts delivery.
The routes announced are candidate locations for further evaluation rather than confirmed commercial operations. Any future services would require coordination with Indian government and aviation authorities and would remain subject to the necessary regulatory approvals.

